MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 73.6 ¤274,477 NL
RO.CH Roche Holding Ltd 58.7 ¤264,409 CH
OR.FR L'Oreal S.A. 52.5 ¤234,650 FR
AZN.GB AstraZeneca PLC 66.9 ¤229,632 GB
NOVN.CH Novartis AG 60.5 ¤222,358 CH

Five Smallest Companies
Symbol Name Grade Market Cap Country
SGE.GB Sage Group plc 58.2 ¤15,134 GB
INDU.C.SE Industrivarden AB Class C 61.8 ¤15,996 SE
LIFCO.B.SE Lifco AB Class B 43.1 ¤16,219 SE
A5G.IE AIB Group plc 73.3 ¤16,326 IE
CARL.B.DK Carlsberg AS Class B 51.2 ¤16,559 DK

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 73.6 32 NL
ACN Accenture Plc Class A 62.2 31 IE
DNB.NO DNB Bank ASA 66.3 28 NO
ALV.DE Allianz SE 45.5 27 DE
NOVO.B.DK Novo Nordisk A/S Class B 72.6 27 DK
ASSA.B.SE ASSA ABLOY AB Class B 53.8 26 SE
TEL TE Connectivity plc 55.3 25 IE
ETN Eaton Corp. Plc 56.9 24 IE
VOLV.B.SE Volvo AB Class B 46.1 24 SE
IFX.DE Infineon Technologies AG 44.3 23 DE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤66,512
Median Market Cap ¤41,977
Avg. 3 Mo. Dollar Vol. ¤148,097,070
Avg. 3 Mo. Trading Vol. 3,696,973
Last Rebalance Date 03/24/2025
Companies Replaced 35
Biggest Sector Increase Consumer Staples
Biggest Sector Decrease Energy

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 15.8
Forward P/E Ratio (12 Mo.) 13.2
Price/Book Ratio 3.1
Avg. Revenue Chg. - 3 Yr 31.3%
Avg. Op. Income Chg. - 3 Yr. 39.1%
Avg. EPS Growth - 3 Yr. 14.5%
Avg. EPS Growth - 1 Yr. 13.8%
Avg. Operating Margin 19.0%
Avg. LT Debt to Total Capital 47.0%
Avg. Return on Equity 17.9%
Dividend Yield 2.9%
Index Average Grade
Europe 100 Index 56.43
Country Breakdown
United Kingdom 17.0%
Sweden 14.0%
Ireland 11.0%
Switzerland 11.0%
Germany 10.0%
Spain 6.0%
Italy 6.0%
Netherlands 6.0%
France 6.0%
Denmark 4.0%
Finland 2.0%
Austria 2.0%
Norway 2.0%
Belgium 1.0%
Czech Republic 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE